Novo Nordisk As vs Dr. Reddys Laboratories Limited & Anr

ik-39726850 Delhi High Court 2 December 2025 • 111 min read

Judges (1)

Manmeet Pritam Singh Arora Delivered

Counsel (15)

Abhay Tandon Counsel Plaintiff Aditya Goel Counsel Defendant Avinash K. Sharma Counsel Defendant Deepankar Mishra Counsel Defendant Gopal Subramanium Counsel Defendant Hemant Singh Counsel Plaintiff J. Sai Deepak Counsel Defendant Kartikeya Tandon Counsel Defendant Mamta Jha Counsel Plaintiff Mohit Goel Counsel Defendant Pavan Bhushan Counsel Defendant Rishabh Paliwal Counsel Plaintiff Shreyansh Gupta Counsel Plaintiff Siddhant Sharma Counsel Plaintiff Sidhant Goel Counsel Defendant

Parties (2)

Dr. Reddys Laboratories Limited Defendant Novo Nordisk AS Plaintiff

Case Significance

Novo Nordisk As vs Dr. Reddys Laboratories Limited & Anr is a Delhi High Court decision dated December 2, 2025 (citation: ik-39726850). Patent infringement suit by Novo Nordisk seeking interim injunction against Dr. Reddy's Laboratories for alleged infringement of Suit Patent IN'697 related to semaglutide/liraglutide (GLP-1 receptor agonist drugs for diabetes and obesity). The court examined issues of anticipation by prior publication, obviousness, and evergreening under the Patents Act. The interim injunction was dismissed, with the court finding Novo Nordisk failed to make out a prima facie case and permitting Dr. Reddy's t The case was heard by Justice Manmeet Pritam Singh Arora.

Summary

Patent infringement suit by Novo Nordisk seeking interim injunction against Dr. Reddy's Laboratories for alleged infringement of Suit Patent IN'697 related to semaglutide/liraglutide (GLP-1 receptor agonist drugs for diabetes and obesity). The court examined issues of anticipation by prior publication, obviousness, and evergreening under the Patents Act. The interim injunction was dismissed, with the court finding Novo Nordisk failed to make out a prima facie case and permitting Dr. Reddy's to manufacture the impugned drug in India and export to countries where the plaintiff had no patent, noting the suit patent was expiring on 20 March 2026.

What was the outcome of Novo Nordisk As vs Dr. Reddys Laboratories Limited & Anr?

Patent infringement suit by Novo Nordisk seeking interim injunction against Dr. Reddy's Laboratories for alleged infringement of Suit Patent IN'697 related to semaglutide/liraglutide (GLP-1 receptor a...

Judgment

Read the full judgment on the official India Courts portal.

Read on Indian Kanoon

Source: Indian Kanoon (ik-39726850)